hypogonadism; oral-t therapy; men's health

https://www.mdpi.com/2305-6320/13/1/1# Abstract Symptomatic male hypogonadism, defined by low serum testosterone with associated clinical symptoms, is increasingly treated with testosterone replacement therapy. Traditional oral formulations were limited by hepatotoxicity and poor...

Shalin Shah is the founder & CEO of Marius Pharmaceuticals, the company that partnered with $HIMS to launch oral testosterone (KYZATREX). We discuss how the partnership came about, the benefits of teaming up with HIMS, and the future of TRT. Chapters (00:41) Origin of the partnership...